Malignancy, Female Reproductive System without CC/MCC
Major Diagnostic Category 13·Grouped by diagnosis·FY 2027
MS-DRG 756 is a Medical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 13 (MDC 13) without a significant Complication or Comorbidity. It maps to 58 ICD-10-CM diagnosis codes. For FY 2027 it carries a relative weight of 0.8645 with a geometric mean length of stay of 2 days and an arithmetic mean of 2.5 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.
Advertisements
FY 2027 payment data
From Table 5 of the FY 2027 IPPS Final Rule (CMS).
- Relative weight:
- 0.8645 (payment multiplier vs. the average case (1.0))
- Geometric mean stay:
- 2 days (used for transfer payments)
- Average stay:
- 2.5 days (arithmetic mean)
- Post-acute transfer policy:
- No (not subject to it)
Same condition, other severity levels
CMS splits one condition into separate DRGs by how sick the patient is. With MCC pays more than with CC, which pays more than without CC/MCC.
Diagnosis codes (58)
As the principal diagnosis, these ICD-10-CM codes can group to DRG 756. 100% of the codes listed are billable.
- C51.0Malignant neoplasm of labium majus
- C51.1Malignant neoplasm of labium minus
- C51.2Malignant neoplasm of clitoris
- C51.8Malignant neoplasm of overlapping sites of vulva
- C51.9Malignant neoplasm of vulva, unspecified
- C52Malignant neoplasm of vagina
- C53.0Malignant neoplasm of endocervix
- C53.1Malignant neoplasm of exocervix
- C53.8Malignant neoplasm of overlapping sites of cervix uteri
- C53.9Malignant neoplasm of cervix uteri, unspecified
- C54.0Malignant neoplasm of isthmus uteri
- C54.1Malignant neoplasm of endometrium
- C54.2Malignant neoplasm of myometrium
- C54.3Malignant neoplasm of fundus uteri
- C54.8Malignant neoplasm of overlapping sites of corpus uteri
- C54.9Malignant neoplasm of corpus uteri, unspecified
- C55Malignant neoplasm of uterus, part unspecified
- C56.1Malignant neoplasm of right ovary
- C56.2Malignant neoplasm of left ovary
- C56.3Malignant neoplasm of bilateral ovaries
- C56.9Malignant neoplasm of unspecified ovary
- C57.00Malignant neoplasm of unspecified fallopian tube
- C57.01Malignant neoplasm of right fallopian tube
- C57.02Malignant neoplasm of left fallopian tube
- C57.10Malignant neoplasm of unspecified broad ligament
- C57.11Malignant neoplasm of right broad ligament
- C57.12Malignant neoplasm of left broad ligament
- C57.20Malignant neoplasm of unspecified round ligament
- C57.21Malignant neoplasm of right round ligament
- C57.22Malignant neoplasm of left round ligament
- C57.3Malignant neoplasm of parametrium
- C57.4Malignant neoplasm of uterine adnexa, unspecified
- C57.7Malignant neoplasm of other specified female genital organs
- C57.8Malignant neoplasm of overlapping sites of female genital organs
- C57.9Malignant neoplasm of female genital organ, unspecified
- C58Malignant neoplasm of placenta
- C76.3Malignant neoplasm of pelvis
- C79.60Secondary malignant neoplasm of unspecified ovary
- C79.61Secondary malignant neoplasm of right ovary
- C79.62Secondary malignant neoplasm of left ovary
- C79.63Secondary malignant neoplasm of bilateral ovaries
- C79.82Secondary malignant neoplasm of genital organs
- D06.0Carcinoma in situ of endocervix
- D06.1Carcinoma in situ of exocervix
- D06.7Carcinoma in situ of other parts of cervix
- D06.9Carcinoma in situ of cervix, unspecified
- D07.0Carcinoma in situ of endometrium
- D07.1Carcinoma in situ of vulva
- D07.2Carcinoma in situ of vagina
- D07.30Carcinoma in situ of unspecified female genital organs
- D07.39Carcinoma in situ of other female genital organs
- D39.0Neoplasm of uncertain behavior of uterus
- D39.10Neoplasm of uncertain behavior of unspecified ovary
- D39.11Neoplasm of uncertain behavior of right ovary
- D39.12Neoplasm of uncertain behavior of left ovary
- D39.2Neoplasm of uncertain behavior of placenta
- D39.8Neoplasm of uncertain behavior of other specified female genital organs
- D39.9Neoplasm of uncertain behavior of female genital organ, unspecified
